SWOG CTP Selects Florence Healthcare to Support Trial Operations
Florence Healthcare has announced that its digital research platform, Florence eBinders, will support clinical trial operations for SWOG Clinical Trials Partnerships, LLC (SWOG CTP), formerly the Southwest Oncology Group.
SWOG CTP is an independent company formed by The Hope Foundation, the public charity of the SWOG Cancer Research Network. SWOG CTP conducts non-federally funded trials with sites that are members of SWOG’s network of nearly 12,000 researchers at over 1,300 hospitals, clinics, and cancer centers in 47 states.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
